Actively Recruiting
Menthol, Inflammation, and Nicotine Transition Study
Led by Rosalind Franklin University of Medicine and Science · Updated on 2026-04-16
68
Participants Needed
1
Research Sites
166 weeks
Total Duration
On this page
Sponsors
R
Rosalind Franklin University of Medicine and Science
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.
CONDITIONS
Official Title
Menthol, Inflammation, and Nicotine Transition Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women between 21-85 years old
- Currently uses menthol cigarettes
- Daily smoking rate of 5 cigarettes/day for 1 year
- Currently own and regularly use an iOS/Android smartphone device able to download the LifeData application
- Able to read and communicate fluently in English
You will not qualify if you...
- Currently pregnant or breastfeeding
- Actively trying to quit smoking
- Current heavy alcohol use
- Frequent use of non-menthol cigarettes, other smoking products, or illicit substances
- History of severe medical/psychiatric condition or treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rosalind Franklin University of Medicine and Science
North Chicago, Illinois, United States, 60064
Actively Recruiting
Research Team
N
Nancy C Jao, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here